Stock 2616 CSTONE PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart CStone Pharmaceuticals

Equities

2616

KYG2588M1006

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:34 2024-07-17 EDT 		5-day change 1st Jan Change
1.24 HKD +1.64% Intraday chart for CStone Pharmaceuticals +0.81% -45.37%
07-03 CStone Pharmaceuticals Grants Exclusive Promotion Rights for Tumor Drug in China to Jiangsu Hengrui Medicine MT
07-03 Voluntary Announcement - CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals Co., Ltd Enter into an Exclusive Promotion Agreement of AYVAKIT® (avapritinib tablets) in Mainland China CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CSTONE PHARMACEUTICALS Stock CStone Pharmaceuticals
 199M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 118B
ARGENX SE Stock argenx SE
 27.87B -
BIONTECH SE Stock BioNTech SE
 20.95B -
GENMAB A/S Stock Genmab A/S
 16.92B
  1. Stock Market
  2. Equities
  3. 2616 Stock
  4. Charts CStone Pharmaceuticals
  5. Sector Chart